These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 33550851)

  • 21. A Modern History RAAS Inhibition and Beta Blockade for Heart Failure to Underscore the Non-equivalency of ACEIs and ARBs.
    Hyman DA; Siebert VR; Birnbaum GD; Alam M; Birnbaum Y
    Cardiovasc Drugs Ther; 2020 Apr; 34(2):215-221. PubMed ID: 32219664
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A systematic review of the pharmacological management of aortic root dilation in Marfan syndrome.
    Thakur V; Rankin KN; Hartling L; Mackie AS
    Cardiol Young; 2013 Aug; 23(4):568-81. PubMed ID: 23083542
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Drug treatment for chronic heart failure with reduced ejection fraction].
    Rickenbacher P
    Ther Umsch; 2011 Feb; 68(2):71-9. PubMed ID: 21271537
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Angiotensin receptor blockers and β blockers in Marfan syndrome: an individual patient data meta-analysis of randomised trials.
    Pitcher A; Spata E; Emberson J; Davies K; Halls H; Holland L; Wilson K; Reith C; Child AH; Clayton T; Dodd M; Flather M; Jin XY; Sandor G; Groenink M; Mulder B; De Backer J; Evangelista A; Forteza A; Teixido-Turà G; Boileau C; Jondeau G; Milleron O; Lacro RV; Sleeper LA; Chiu HH; Wu MH; Neubauer S; Watkins H; Dietz H; Baigent C;
    Lancet; 2022 Sep; 400(10355):822-831. PubMed ID: 36049495
    [TBL] [Abstract][Full Text] [Related]  

  • 25. First-line drugs inhibiting the renin angiotensin system versus other first-line antihypertensive drug classes for hypertension.
    Xue H; Lu Z; Tang WL; Pang LW; Wang GM; Wong GW; Wright JM
    Cochrane Database Syst Rev; 2015 Jan; 1():CD008170. PubMed ID: 25577154
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers on cardiovascular events in patients with heart failure: a meta-analysis of randomized controlled trials.
    Tai C; Gan T; Zou L; Sun Y; Zhang Y; Chen W; Li J; Zhang J; Xu Y; Lu H; Xu D
    BMC Cardiovasc Disord; 2017 Oct; 17(1):257. PubMed ID: 28982370
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Perioperative angiotensin-converting enzyme inhibitors or angiotensin II type 1 receptor blockers for preventing mortality and morbidity in adults.
    Zou Z; Yuan HB; Yang B; Xu F; Chen XY; Liu GJ; Shi XY
    Cochrane Database Syst Rev; 2016 Jan; 2016(1):CD009210. PubMed ID: 26816003
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Meta-analysis: angiotensin-receptor blockers in chronic heart failure and high-risk acute myocardial infarction.
    Lee VC; Rhew DC; Dylan M; Badamgarav E; Braunstein GD; Weingarten SR
    Ann Intern Med; 2004 Nov; 141(9):693-704. PubMed ID: 15520426
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The treatment gap in patients with chronic systolic heart failure: a systematic review of evidence-based prescribing in practice.
    Chin KL; Skiba M; Tonkin A; Reid CM; Liew D; Krum H; Hopper I
    Heart Fail Rev; 2016 Nov; 21(6):675-697. PubMed ID: 27465132
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Renin-Angiotensin System Inhibitors and Kidney and Cardiovascular Outcomes in Patients With CKD: A Bayesian Network Meta-analysis of Randomized Clinical Trials.
    Xie X; Liu Y; Perkovic V; Li X; Ninomiya T; Hou W; Zhao N; Liu L; Lv J; Zhang H; Wang H
    Am J Kidney Dis; 2016 May; 67(5):728-41. PubMed ID: 26597926
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Outcomes of a Pharmacist-Managed Heart Failure Medication Titration Assistance Clinic.
    Bhat S; Kansal M; Kondos GT; Groo V
    Ann Pharmacother; 2018 Aug; 52(8):724-732. PubMed ID: 29463107
    [TBL] [Abstract][Full Text] [Related]  

  • 32. beta-blocker therapy in patients after aortic valve replacement for aortic regurgitation.
    Matsuyama K; Ueda Y; Ogino H; Sugita T; Sakakibara Y; Matsubayashi K; Nomoto T; Yoshimura S; Yoshioka T
    Int J Cardiol; 2000 Mar; 73(1):49-53. PubMed ID: 10748310
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Angiotensin-converting enzyme inhibitors versus angiotensin receptor blockers in hypertensive patients with myocardial infarction or heart failure: a systematic review and meta-analysis.
    Ohtsubo T; Shibata R; Kai H; Okamoto R; Kumagai E; Kawano H; Fujiwara A; Kitazono T; Murohara T; Arima H
    Hypertens Res; 2019 May; 42(5):641-649. PubMed ID: 30948834
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of blood pressure lowering on outcome incidence in hypertension: 4. Effects of various classes of antihypertensive drugs--overview and meta-analyses.
    Thomopoulos C; Parati G; Zanchetti A
    J Hypertens; 2015 Feb; 33(2):195-211. PubMed ID: 25485720
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacotherapy Treatment Patterns, Outcomes, and Health Resource Utilization Among Patients with Heart Failure with Reduced Ejection Fraction at a U.S. Academic Medical Center.
    Bress AP; King JB; Brixner D; Kielhorn A; Patel HK; Maya J; Lee VC; Biskupiak J; Munger M
    Pharmacotherapy; 2016 Feb; 36(2):174-86. PubMed ID: 26841333
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Precise Drug Sequential Therapy Can Improve the Cardioversion Rate of Atrial Fibrillation with Valvular Disease after Radiofrequency Ablation.
    Li T; Qian Y
    Methods Mol Biol; 2020; 2204():145-159. PubMed ID: 32710322
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Patient Perceptions and Familiarity With Medical Therapy for Heart Failure.
    Samsky MD; Lin L; Greene SJ; Lippmann SJ; Peterson PN; Heidenreich PA; Laskey WK; Yancy CW; Greiner MA; Hardy NC; Kavati A; Park S; Mentz RJ; Fonarow GC; O'Brien EC
    JAMA Cardiol; 2020 Mar; 5(3):292-299. PubMed ID: 31734700
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Angiotensin-converting enzyme inhibitors/angiotensin receptor blockers, β-blockers or both in incident end-stage renal disease patients without cardiovascular disease: a propensity-matched longitudinal cohort study.
    Ferreira JP; Couchoud C; Gregson J; Tiple A; Glowacki F; London G; Agarwal R; Rossignol P
    Nephrol Dial Transplant; 2019 Jul; 34(7):1216-1222. PubMed ID: 30590716
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Renin-angiotensin blockade in heart failure with preserved ejection fraction: a systematic review and meta-analysis.
    Khan MS; Fonarow GC; Khan H; Greene SJ; Anker SD; Gheorghiade M; Butler J
    ESC Heart Fail; 2017 Nov; 4(4):402-408. PubMed ID: 28869332
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Angiotensin receptor blockers for heart failure.
    Heran BS; Musini VM; Bassett K; Taylor RS; Wright JM
    Cochrane Database Syst Rev; 2012 Apr; 2012(4):CD003040. PubMed ID: 22513909
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.